GIM
Granahan Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-52,006
| Closed | -$3.4M | – | 172 |
|
|
2022
Q3 | $3.4M | Buy |
52,006
+2,230
| +4% | +$146K | 0.11% | 144 |
|
|
2022
Q2 | $3.03M | Sell |
49,776
-42,330
| -46% | -$2.57M | 0.1% | 147 |
|
|
2022
Q1 | $5.78M | Buy |
92,106
+44,565
| +94% | +$2.8M | 0.14% | 127 |
|
|
2021
Q4 | $3.6M | Buy |
47,541
+2,211
| +5% | +$168K | 0.07% | 164 |
|
|
2021
Q3 | $5.07M | Sell |
45,330
-5,962
| -12% | -$667K | 0.1% | 149 |
|
|
2021
Q2 | $8.3M | Buy |
51,292
+3,017
| +6% | +$488K | 0.15% | 125 |
|
|
2021
Q1 | $5.88M | Sell |
48,275
-8,922
| -16% | -$1.09M | 0.12% | 132 |
|
|
2020
Q4 | $8.76M | Buy |
57,197
+17,863
| +45% | +$2.73M | 0.2% | 101 |
|
|
2020
Q3 | $3.29M | Sell |
39,334
-4,291
| -10% | -$359K | 0.11% | 129 |
|
|
2020
Q2 | $3.21M | Buy |
43,625
+9,498
| +28% | +$698K | 0.12% | 127 |
|
|
2020
Q1 | $1.45M | Sell |
34,127
-455
| -1% | -$19.3K | 0.08% | 151 |
|
|
2019
Q4 | $2.11M | Hold |
34,582
| – | – | 0.1% | 139 |
|
|
2019
Q3 | $1.42M | Buy |
34,582
+2,655
| +8% | +$109K | 0.08% | 150 |
|
|
2019
Q2 | $1.5M | Sell |
31,927
-730
| -2% | -$34.4K | 0.07% | 155 |
|
|
2019
Q1 | $1.17M | Sell |
32,657
-2,335
| -7% | -$83.4K | 0.06% | 167 |
|
|
2018
Q4 | $1M | Sell |
34,992
-12,350
| -26% | -$353K | 0.07% | 165 |
|
|
2018
Q3 | $2.1M | Sell |
47,342
-47,449
| -50% | -$2.1M | 0.11% | 153 |
|
|
2018
Q2 | $5.57M | Buy |
94,791
+8,048
| +9% | +$473K | 0.34% | 93 |
|
|
2018
Q1 | $3.97M | Sell |
86,743
-54,397
| -39% | -$2.49M | 0.29% | 104 |
|
|
2017
Q4 | $3.31M | Sell |
141,140
-122,606
| -46% | -$2.88M | 0.26% | 116 |
|
|
2017
Q3 | $4.71M | Buy |
263,746
+89,839
| +52% | +$1.61M | 0.39% | 93 |
|
|
2017
Q2 | $2.79M | Buy |
+173,907
| New | +$2.79M | 0.26% | 116 |
|